NCT05546437Completed
A Multicenter Retrospective Review to Evaluate the Feasibility of Dye Marking Using the Ion Endoluminal System
Source: ClinicalTrials.gov · Last updated 8 Mar 2024
Brief summary (registry, in English)
The overall objective of this study is to assess the ability of the Ion Endoluminal System to perform pleural based tissue dye marking in anticipation of a lung resection.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 288 (actual)
- First submitted
- 14 Sept 2022
- Start date
- 22 Jul 2022
- Primary completion date
- 30 Apr 2023
- Lead sponsor
- Intuitive Surgical
- Diseases
- Lung cancer
- NCT number
- NCT05546437
What you commit to
- Study type: Observational
- Participants enrolled: 288
- From 22 Jul 2022 to the primary completion date, 30 Apr 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Resection not performed following dye marking procedure
Who the study is looking for
- Subject is 18 years or older at the time of the procedure.
- Dye marking attempted/performed using the Ion Endoluminal Platform
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Orlando Health Coordinator of this site? Confirm its status | Orlando | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.